Ceramide NanoLiposome in Patients With Advanced Solid Tumors
Clinical trial NCT02834611 · COMPLETED
Trial details
- NCT number
- NCT02834611
- Sponsor
- Keystone Nano, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-15
- Primary completion
- 2023-08-03
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.